Early life stages of zebrafish (Danio rerio, zf) are gaining attention as an alternative in vivo test system for drug discovery, early developmental toxicity screenings and chemical testing in ecotoxicological and toxicological testing strategies. Previous studies have demonstrated transcriptional evidence for xenobiotic metabolizing enzymes (XME) during early zf development. However, elaborate experiments on XME activities during development are incomplete. In this work, the intrinsic activities of representative phase I and II XME were monitored by transformation of putative zf model substrates analyzed using photometry and high pressure liquid chromatography techniques. Six different defined stages of zf development (between 2.5 h postfertilization (hpf) to 120 hpf) were investigated by preparing a subcellular fraction from whole organism homogenates. We demonstrated that zf embryos as early as 2.5 hpf possess intrinsic metabolic activities for esterase, Aldh, Gst, and Cyp1a above the methodological detection limit. The activities of the enzymes Cyp3a and Nat were measurable during later stages in development. Activities represent dynamic patterns during development. The role of XME activities revealed in this work is relevant for the assessing toxicity in this test system and therefore contributes to a valuable characterization of zf embryos as an alternative testing organism in toxicology.
The early life stages of zebrafish (zf, Danio rerio) are increasingly used as model organisms for drug discovery, early developmental toxicity screenings and tiered chemical testing strategies in ecotoxicological and toxicological assessment (Embry et al., 2010; Hill et al., 2005; McCollum et al., 2011) . Studies using zf eggs and embryos until day 5 after fertilization (onset of exogenous feeding) are regarded as nonprotected animal experiments under European animal welfare legislation (EU, 2010; Str€ ahle et al., 2012) and this has fostered their implementation as an alternative in vivo testing model. For example, the recently validated fish embryo toxicity test (OECD, 2013 ) is advocated as an alternative to the traditional acute fish test (Braunbeck et al., 2015; Busquet et al., 2014; OECD, 1992) . Another example is the inclusion of zf early life stages into a tiered testing strategy to assess teratogenicity of pharmaceutical compounds (Augustine-Rauch et al., 2016) . As reported by the authors, the assay shows good predictivity and concordance for a potential in vivo classification. This report and others (eg, Ball et al., 2014; Gustafson et al., 2012) are accompanied to the proposal for the zf embryotoxicity test in the current process of updating the ICH S5 guideline for preclinical testing of pharmaceuticals (ICH, 2015a,b) . Overall, this progression is primarily driven in the context of animal welfare by the 3R-principle (Russell and Burch, 1959) to strongly promote the development of alternative methods and to use such data for substance evaluation under different regulatory frameworks.
The zf, especially its early life stages, offers many advantages making it a favorable system for toxicity testing. First, it is an intact organism with similar development, anatomy and physiology (Gunnarsson et al., 2008; Howe et al., 2013) as higher vertebrates. In particular, molecular pathways regulating development in zf and mammals are conserved (Pauli et al., 2012) . Second, the externally developing embryo grows rapidly and is semi-transparent, thus allowing easy visualization of internal organs. Third, zf are easy to breed, have high fecundity and are inexpensive to maintain. A large literature database exists documenting zf development including several mutant strains (Sprague et al., 2006) .
Using zf embryos as model organisms to evaluate toxicity raises questions about their xenobiotic metabolic transformation activities. Current literature points towards transcriptional activities of some xenobiotic metabolizing enzymes (XME) already in early developmental stages (Dasmahapatra et al., 2001; Goldstone et al., 2010; Li et al., 2011; Timme-Laragy et al., 2013) . Nevertheless, there is little direct evidence of enzyme activity in most cases. To fully interpret the outcome of toxicity tests it is crucial to understand the metabolism of test substances in the applied experimental system. Better understanding of the metabolic potential in zf during development is an essential step towards achieving better implementation and acceptance of zf embryo models as alternative methods in toxicology.
In this work, we examine the activities of XME of zf embryos over the course of their early development by measuring activities of representative phases I and II XME in the subcellular fraction of the zf.
MATERIALS AND METHODS
Chemicals, Reagents, and Stock Solutions. If not otherwise stated, all chemicals were purchased from Sigma-Aldrich and of p.a. quality. Stock solutions, which were stored at À20 C until use, as well as always freshly prepared solutions of cofactors and additives were prepared as described by Fabian et al. (2013) .
Fish Maintenance and Egg Production. Adult zf (in-house bred wild type fish) were kept in a single pass flow-through system of filtered tap water with adjusted water hardness of 1 mmol/L. Temperature was maintained at 28 C and the photoperiod was 16 h light to 8 h darkness. Fish were fed daily with a commercial diet TetraMinV R (Tetra-Werke, Melle, Germany) as well as freshly hatched live brine shrimp nauplii (Artemia salina). To obtain eggs, 1 pair (1 male and 1 female) were placed in each spawning aquarium overnight. The spawning aquaria (18 Â 8 Â 8 cm) consist of 2 parts: a main container and an insert with a wire mesh bottom to hold the spawning fish and allow the eggs to drop through. Egg clutches were harvested between 1 and 2 h after spawning. Harvested eggs were examined under a stereomicroscope (SteREO Discovery.V12, Carl Zeiss GmbH, Jena, Germany). Only intact fertilized eggs demonstrating homogenous synchronous development (between 8-and 256-cell stage) were used. The developmental stage was determined according to Kimmel et al. (1995) . Sorted eggs from at least 2 clutches were pooled in equal amounts for further use. Each sample consisted of 100 pooled eggs incubated in petri dishes (Ø 9 cm) filled with 20 ml standardized water (ISO, 1996) at 26 C until they reached the desired developmental stage. At least half of the water volume was exchanged daily. Developmental stages of 2.5, 24, 48, 72, 96 , and 120 h postfertilization (hpf) were investigated. Eggs larvae were checked for proper development and stage before the subsequent steps. Eggs/larvae were frozen with liquid nitrogen in portions of n ¼ 100, 150, 200, or 350 per 2 ml reaction tube with minimal residual water and stored at À80 C until the next working steps. For each stage at least 3 replicates were used with n ¼ 100-350 6 10%. The error of 6 10% for the embryo number was conservatively estimated considering the following points: (1) the eggs were counted at least twice in portions of 100 before incubation (counting error); (2) per 100 larvae max. 1-2 eggs did not appear to develop well until 120 hpf; (3) loss due to handling when transferring embryos to the reaction tube. For Nat1 measurement, only fresh eggs/larvae were used. All studies were performed in an AAALAC (Association for Assessment and Accreditation of Laboratory Animal Care International) certified laboratory.
Subcellular Fraction. Samples were homogenized with 4.5 ml homogenization buffer (0.025 M saccharose, 1 mM ethylene-diamine tetra-acetic acid [EDTA]) per embryo/larva. Homogenization was performed with 1 metal beat per tube for 5 min with TissueLyserII (Quiagen, Hilden, Germany) at a frequency of 10 s/ min. The equipment was cooled at À20 C before use to prevent the samples from overheating due to the fast movement. A refined of sample preparation was used to prepare S9 fractions: triplicates of 2.5, 48, 96, and 120 hpf eggs/larvae with n ¼ 350 were homogenized with a ratio of 1 ml homogenization buffer per egg/larva by agitating for 10 min at 10 rounds/min and additional ultrasonification for 5 min on ice. The subcellular fraction was prepared according to Fabian et al. (2013) and stored at À80 C. In detail, 2 ml of 3 or 4 pooled S9 samples per stage (means n ¼ 500) per replicate were centrifuged at 100 000 g and 4 C for 1 h. The supernatant containing the cytosolic fraction was kept to measure the cytosolic XME activities. The pellet was resuspended in 1 volume (2 ml) wash medium (0.15 M KCl) and centrifuged again. The pellet, containing the microsomal fraction, was then dissolved in 300 ml resuspension buffer (1 mM glutathione, 1 mM EDTA, 4 mM MgCl 2 , 100 mM KH 2 PO 4 pH 7.5, 200 ml/l glycerol 20%).
Enzyme Activity Assays. Examination of enzyme activities within the subcellular fraction was performed as described by Fabian et al. (2013) with the following specific modifications: cytochrome P450 dependent monooxygenases (Cyp450) activities were investigated using the S9 fraction of the refined preparation (only stages of 2.5, 48, 96, and 120 hpf). Triplicates were incubated using 120-200 mg S9 protein within the reaction mixture for 60 min. Fluorescein diacetate-dependent esterase activity was determined using a longer incubation time of 20 min than mentioned in Fabian et al. (2013) . The alcohol dehydrogenase (Adh) activity assay was performed using triplicates of the cytosolic fraction of all investigated stages, as well as triplicates of the refined S9 fraction of the 120 hpf stage. The aldehyde dehydrogenase (Aldh) assay was also performed using the cytosolic fraction and additionally with S9 samples of all investigated stages as well as with the refined S9 fraction of the stages of 2.5, 48, and 96 hpf. Within the active incubation of both assays, cytosolic and S9 protein were used at 50-75 mg and S9 (refined) protein was used at 300-500 mg per 250 ml incubate. Also for assaying N-acetyl transferase 1 (Nat1) activity, the S9 protein concentration was adjusted to 50-75 mg per incubate. The Nat1 assay was run in duplicates for each developmental stage. Glutathione-S-transferase (Gst) activity was determined by measuring the transformation of the substrate 1-chloro-2,4-dinitrobenzene (CDNB) to glutathione-DNB (GS-DNB) conjugate as described by Habig et al. (1974) . The GS-DNB conjugate absorbs at k ¼ 340 nm. The assay was performed as described in the manufacturer's manual (Gst Assay Kit, Sigma Aldrich, Munich, Germany). The Gst activity was calculated from the linear slope of the rising absorbance of GS-DNB as stated by the manufacturer and following the Lambert-Beer law.
The subcellular fraction of the liver of male Wistar rats (delivered by Charles River, Sulzfeld, Germany) was used as a positive control for each assay. Heat denatured controls (HDC) were used to determine background activity which is not linked to the target enzyme. Therefore, 1 volume (>33 ml) of each triplicate per stage and subcellular fraction was pooled and heated to 99 C for 15 min under continuous agitation (450 rpm, Thermomix Comfort, Eppendorf, Hamburg, Germany). The precipitated protein was pelleted by centrifugation at 10 000 g for 5 min at 4 C and the supernatant was used as HDC in the assays. The amount of protein in each sample was determined according to Bradford (1976) . As standard, bovine serum albumin was adjusted in concentrations between 0.01 and 2 mg/ml. In order to ensure successful preparation of the microsomal fraction, NADPH-cytochrome c reductase activity was determined following Fabian et al. (2013) . The samples, HDC and subsequent controls were measured in triplicate with a frequency of 6 measurements/s for 4 min.
Calculation of Enzyme Activities. Enzymatic activities were derived during incubation when the absorption or fluorescence increase time was linear. Background (HDC) values were subtracted from values of the 2 time points t 0 (beginning of linearity) and t linear (increment is still linear). The specific transformation rate was then calculated by subtracting the value of t 0 from t linear divided by the respective time frame of t 0 -t linear and multiplied by the dilution factor of the sample in the incubation mixture.
Level of Detection and Level of Quantification. In order to distinguish enzymatically transformed substrates/cofactors from an unspecific abiotic transformation, a level of detection (LOD) and level of quantification (LOQ) margin for enzyme activity was determined using the approach by Fabian et al. (2013) and J€ ackh et al.
(2011) for photometric measurements: The fluorescence or absorbance values of at least 9 individual measurements of reaction mix without protein (buffer controls) were inserted into the general enzyme activity calculation described above. The mean of these calculated "activities" of the negative controls plus their 3-fold standard deviation was assigned to the LOD of the assay in n mol per min and ml subcellular fraction. The LOQ was defined as the 2-fold LOD. For the Adh and Aldh assay, negative control samples were incubations with protein but without substrate. The corresponding activities were subtracted from active incubations with substrate. For Nat1 assay using HPLC, the LOD was specified using the Chromeleon V R software as 3 times the signal to noise ratio (S/N) with a range of 1 min within the HDC at the same retention time as the product. Based on Chromeleon V R software, the LOQ was calculated as 10*S/N using as already described elsewhere (J€ ackh et al., 2011) .
Statistical Analysis. One-way analysis of variance (ANOVA) followed by the posthoc analysis (Least Significant Difference test) with Bonferron ıs multiple comparison adjustment was performed using the software GraphPad Prism 5 V R to test for statistically significant differences in enzyme activities between the different developmental stages (a ¼ 5%).
RESULTS
In order to examine intrinsic xenobiotic metabolism activities in defined early life stages of zf, the turnover rates of several XME were monitored by model substrate transformation in subcellular fractions prepared from whole body homogenates. For this purpose photometry and HPLC were used to detect the increase in absorbance or fluorescence over time due to enzymatic product or cofactor formation. Refined S9 fraction samples of the stages 2.5, 48, 96, and 120 hpf were prepared for alkoxyresorufin dealkylase assays. The increase in fluorescence as a result of resorufin formation over 1 h was measured every 60 s and 3 times for all triplicates of the given developmental stages. Three different substrates were used separately in order to detect Cyp450 enzyme activity. Oxidation of the substrates 7-Oethylresorufin (EROD assay), 7-O-Benzylresorufin (BROD assay), and 7-O-pentoxylresorufin (PROD assay) are used to represent the zf Cyp1s of different metabolic effectiveness and specificity (Scornaienchi et al., 2010; Stegeman et al., 2015) . In both BROD and PROD assays, no activity above the methodological LOD was measured for any of the investigated developmental stages using the refined S9 fraction. The samples of the 120 hpf stage revealed a minor BROD activity >LOD but still <LOQ. Clear EROD activity above the respective LOQ (Figure 1 ) was measured for stages 96 and 120 hpf. Furthermore, a dynamic EROD activity pattern was observed among the investigated developmental stages. For samples of 2.5 hpf an activity above the LOD but lower than LOQ was detected, which then decreased below LOD at 48 hpf and thereafter increased to quantifiable values at 96 and 120 hpf.
Fluorescein diacetate-dependent esterase activity was investigated in the subcellular S9 fraction. The transformation rate of the substrate fluorescein diacetate into fluorescein was monitored by fluorescence detection. LOD for esterase assay was between 0.25 and 0.29 pmol fluorescein per min and embryo. All investigated stages demonstrated activity above the LOQ (Figure 2 ). Esterase activities between the investigated stages were assessed by 1-way ANOVA followed by posthoc analysis with Bonferroni's multiple comparison test. There was no difference in esterase activity between 2.5 and 72 hpf. However, stages of 96 and 120 hpf were significantly different from the younger ones and showed an approximately 2-fold higher activity for esterase. Although the mean values differ between 96 and 120 hpf, there was no statistical difference in the esterase activity.
Activities of the enzyme Adh were investigated within the cytosolic fraction of all stages and in the S9 fraction of 120 hpf samples which were prepared using the refined homogenization procedure. None of the investigated samples demonstrated activity above the LOD (¼16-190 pmol ethanol/min/embryo in cytosol and 14 pmol ethanol/min/embryos in S9; Table 1 ). The LOD in these 2 cases was derived using the background measurements instead of the buffer control values. The background measurements were pooled out of the 3 replicates of each developmental stage and contained the protein without substrate (ethanol or propionaldehyde). With the cytosolic fraction no Aldh activity was measured above the LOD until 72 hpf (Table 1) . However, samples of the 96 and 120 hpf stages showed activities of 12.9 6 8.7 pmol propionaldehyde per min and embryo (LOD ¼ 1.5; LOQ ¼ 2.9 pmol/min/embryo) and 15.2 6 3.2 pmol/min/embryo (LOD ¼ 2.6; LOQ ¼ 5.3 pmol/min/embryo). In another run Aldh activities in samples of the refined S9 preparation were investigated. Here, an Aldh activity above LOQ (0.9 and 0.7 pmol/min/embryo) was detected for samples of the 2.5 hpf (5.2 6 2.3 pmol propionaldehyde/min/embryo) and 96 hpf (12.4 6 2.5 pmol propionaldehyde/min/embryo) stages, respectively. No Aldh activity above LOD (4.7 pmol/min/embryo) was detected for the 48 hpf samples.
Nat1 activity was investigated using a fresh S9 fraction on the same day of sample preparation because enzyme activity cannot be preserved by freezing the sample. The transformation rate of the model substrate para-aminobenzoic acid (PABA) into acPABA during incubation was analyzed after 30 min. Quantitative analysis of the product acPABA was performed using HPLC and UV-Vis. The LOD was determined at 0.33 mM acPABA and the LOQ at 1.12 mM using the S/N ratio. Correspondingly, a LOD for the Nat enzymes activity was determined at 4.8-5.7 * 10 À2 pmol acPABA per min and embryo (dashed line in the graph; Figure 3 ). The LOQ was 0.16-0.19 pmol acPABA/min/embryo (solid line in the graph, Figure 3 ). The samples of 48 hpf and older showed a quantifiable Nat activity. In contrast, for samples of 2.5 and 24 hpf, minor Nat activity was detected above the LOD but below LOQ. Measured Nat activity demonstrated a dynamic pattern over the developmental stages investigated. Samples of 120 hpf showed significantly higher Nat activity than all other stages investigated, whereas activities of samples at 48 and 96 hpf did not significantly differ from each other. In comparison to these activities, the samples of 72 hpf stages showed significantly higher Nat activity, however it was still lower than the activity of 120 hpf stage samples. Gst activities far above the LOD were obtained at all stages. The LOQ here was 90-110 pmol/min/embryo. Generally, an increasing trend in activity at older stages was evident. Stages of 48-120 hpf did not significantly differ in their Gst activity (Figure 4 ). This was also true for the stages between 2.5 and 96 hpf. The samples of 24 hpf embryos showed a significantly lower Gst activity compared with those of 120 hpf. Gst activities of 142 6 4 nmol/mg protein/min were recorded for the positive control male rat liver S9. The LOD of the Gst activity assay may vary depending on the time between substrate injection and measurement. In order to overcome these effects all samples were measured on 1 microtiter plate and were treated identically. HDC samples did not fit on the microtiter plate and were measured separately. HDC turnover rates showed the same results as the buffer controls. 
DISCUSSION
The goal of this work was to examine the intrinsic activities of XME of zf early life stages. This was achieved by in vitro detection of model substrate transformation in subcellular fractions prepared from whole body homogenates. Three different substrates were used separately to detect zf Cyp450 enzyme activity. As demonstrated in recombinant assays in yeast and Escherichia coli, oxidation of the substrate 7-O-ethylresorufin (EROD assay) represents mostly Cyp1a, to a lesser extent Cyp1c2 and to a minimal amount Cyp1b1, Cyp1c1, and Cyp1d1. Among the 5 zf Cyp1s, metabolism of (7-O-benzylresorufin BROD assay) is mostly represented by Cyp1a and Cyp1c2 activities, but in lower and different metabolic effectiveness than EROD. Finally, the very low activity for (7-O-pentoxylresorufin PROD assay) can most likely be attributed to all zf CYP1s except for Cyp1b with no demonstrated catalytic activity (Scornaienchi et al., 2010; Stegeman et al., 2015) . The dynamic EROD activity pattern observed in this work is consistent with other reports (Br€ aunig et al., 2015; Gonzalez-Doncel et al., 2015; Otte et al., 2010; Saad et al., 2014; Schiwy et al., 2015) and is assignable to catalytic activity predominantly from Cyp1a, followed by Cyp1c2, Cyp1c1, Cyp1d1, and Cyp1b1 (descending order). The studies support the pattern of detectable ERODactivity at very early stages of development, followed by no detectable levels as development proceeds and enzyme activity again after hatching and in the later stages. However, previous studies have not reported or defined the methodological LOD as well as the LOQ in order to distinguish enzyme activity from abiotic substrate transformation. A 3-fold SD serves as the margin of confidence. For other CYP450 enzyme substrates, neither PROD nor BROD activity was demonstrated earlier the methodological LOD in any of the stages investigated using this method, with the exception of the 120 hpf samples which revealed BROD activity above LOD, but still lower than LOQ. This lack of quantitative activity for BROD activity in early life stages was also reported by Verbueken et al. (2014) for zf embryos at 24 hpf. Catalytic activity for EROD above LOQ, for BROD above LOD and for PROD below LOD at the 120 hpf stage are in line with the specific substrate activities where EROD shows highest activity over all zf Cyp1s followed by BROD and PROD (Stegeman et al., 2015) . Overall, the pattern of Cyp450 enzyme activities is in good concordance with low and changing mRNA levels reported for the corresponding genes at these stages (Goldstone et al., 2010; Jö nsson et al., 2007) . In addition, Jones et al. (2012) reported detection of specific metabolites of certain investigated drugs exposed to 3 dpf zf larvae, providing evidence of their metabolism due to Cyp450 activities similar to mammals. The latter finding also stresses the biological relevance of Cyp450 activities in zf early life stages used for chemical substance testing. To summarize, even though in vitro enzyme activity was only demonstrated for certain Cyp450 subclasses using the method described herein, an abundance of evidence indicates that embryonic stages of zf are able to transform several substances in a similar manner to that observed in mammals (Jones et al., 2012; Weigt et al., 2011) .
As phase I enzymes, esterases play an important role in transforming a large range of compounds including environmental chemicals and drugs. Within this work, esterase activities in zf embryos from 2.5 to 120 hpf are above LOQ. The results are in agreement with findings generated using other model esterase substrates and using a different procedure for preparing the samples (Kü ster, 2005) . Kü ster et al. reported no significant differences in esterase activity within the developmental stages from 12 to 48 hpf which corroborates the present results with no statistical significance between 2.5 and 72 hpf. Brox et al. (2014) report internal concentrations and toxicokinetics of 34 polar analytes, including benzocaine, in zf embryos from 4 to 96 hpf using quantitative HPLC-MS/MS techniques. The authors also report a decreasing internal concentration of the ester. They assume that this finding could be due to metabolism in the organism. This is very likely, as esterases are involved in the metabolism of several cocaine derivatives by ester cleavage (Meinertz et al., 1991) . Especially methyl esters are known to perform transesterifications in the presence of alcohols (Parkinson et al., 2013) . Meinertz et al. (1991) report a toxicokinetic study of a single exposure with radiolabelled benzocaine in adult rainbow trout. The authors found 1 h after dosing 7.6% PABA, 59.7% N-acetylated PABA, 19.5% benzocaine, and 8.0% N-acetylated benzocaine in the urine. After 20 h the proportion changed to 96.9% N-acetylated PABA and 1.0% PABA. These findings support cleavage activities of esterases, resulting in PABA as product. Another metabolic pathway due to Nat activity could be assumed according to the reported metabolite findings. However, at least the Nat enzyme seems to be less active in younger stages of zf embryos until 48 hpf, as discussed later. Nevertheless, one hypothesis could be that especially in early life stages from 2.5 to 48 hpf esterases are primarily responsible for the metabolism of benzocaine. Furthermore, esterases rapidly catalyze the transformation of benzocaine, whereas products of Nats dominate at later stages.
To the best of our knowledge, there are no investigations reporting Adh and Aldh activity in early life stages of zf in published literature. The findings within this work represent the first report of intrinsic Aldh activity as early as 2.5 hpf in zf as well as the absence of measurable activity for Adh in all investigated stages and different subcellular fractions. As several genes for Aldh and Adh are known in zf, no specific attribution can be made to a specific subclass for enzymatic activity or absence thereof. However, findings of Adh5 mRNA which is shown to accept ethanol as substrate were demonstrated for zf embryos between 4 and 120 hpf (Dasmahapatra et al., 2001) . Zebrafish embryos exposed to the proteratogen 2- methoxyethanol, which must be metabolized to the teratogenic methoxyacetic acid, show specific teratogenic effects as early as 24 hpf (Otte and Schultz, unpublished report) . The first dehydration step could also be performed by enzymes other than Adh, but as Aldh has been shown in this work to be active as early as 2.5 hpf after using a refined protocol it cannot be excluded that Adh is also present at activity levels below LOD of the present procedure. This matches the teratogenic effects found in early life stages. This consideration is not only supported by the presence of the above-mentioned adh5 mRNA in zf between 4 and 120 hpf (Dasmahapatra et al., 2001 ) but also by the Adh and Aldh expression pattern in the embryonic stages of mammalian species such as the rat, mouse, guinea pig and also in human fetal liver (Saghir et al., 2012) .
Nat are considered to be phase II enzymes as they catalyze the conjugation of substrates with an acetyl group. To our knowledge, this is the first direct report of Nat1 activity in zf developmental stages between 2.5 and 120 hpf. The toxicokinetic investigations by Brox et al. (2014) and the reported metabolites in rainbow trout (Meinertz, et al., 1991) after exposure to benzocaine, as previously described, also point strongly to NAT activities in principle. Both the substrate benzocaine, as well as the cleavage product of esterase activity which is in the present case PABA, are likely substrates for NAT1. Nevertheless, as in the earlier life stages of zf between 2.5 and 48 hpf Nat activity was lower (<0.2 and 0.3 pmol/min/embryo) than esterase activity (6.0-6.4 pmol/min/embryo), esterase cleavage can be assumed to be the dominant metabolic pathway for benzocaine in these stages.
Currently, 27 gst genes belonging to 9 subclasses have been identified in adult zf (Glisic et al., 2015) . In the zf embryo between 3 and 48 hpf, 19 gst genes were identified, among them subclasses known for xenobiotic metabolism as well as endogenous functions (Timme-Laragy et al., 2013). As CDNB is known to be accepted by a broad range of Gst subclasses, although with different turnover rates, the activity detected in this work may be understood as the sum of many different Gst isoenzymes. Furthermore, Gst isoforms were shown to be present in several tissues other than the liver, such as kidney, brain, gills and intestine for adult zf (Glisic et al., 2015) . This supports the approach adopted in this work using whole body homogenates to investigate Gst activity. Intrinsic Gst enzyme activities were demonstrated for all investigated developmental stages of zf here. Activities are in concordance with the report from Wiegand et al. (2000) for the stages from 2.5 to 48 hpf if referred to mg protein of the S9 fraction. Furthermore, Gst activities support the elimination kinetics reported for zf embryos between 24 and 48 hpf using radiolabelled atrazine (Gö rge and Nagel, 1990) .
This work provides direct evidence that zf embryos as early as 2.5 hpf do possess intrinsic XME activities for esterase, Aldh, Gst, Nat and EROD. Activities also revealed dynamic patterns during development. Only an indication of activity was achieved for other enzyme activities, like BROD and Adh. It may be possible to generate stronger evidence by overcoming methodological challenges. Efforts were made to generate sufficient amounts of microsomes for prehatch stages but with the present protocols and procedures incredibly high amounts of embryos would be needed in order to generate sufficient microsomes to measure enzyme activities. Additionally, the protocols used were originally derived and optimized for mammalian liver tissue and the mammalian enzymes therein. Despite every effort to adapt the protocols (eg, sample preparation, substrate concentration, incubation times, pH values, temperature) the conditions may not be optimal in any respect for measuring in whole zf embryo homogenate. The protocols herein may be further refined to allow for the detection of far lower enzyme activity. Overall good methodological performance in this study is confirmed by the good reproducibility of results for nonexposed male rat liver samples compared with other studies. The rat liver samples served as a control and were run in parallel to the measurements in fish embryos with the protocol described herein. The enzyme activities in all assays used resembled the activities observed in other studies using nonexposed male rat liver (data not shown; Blatz and Vogel et al., unpublished data) . The concept of defining LODs and LOQs is an essential aspect of reporting of enzyme activities as this allows an objective determination of levels where enzyme activity can be methodologically detected and where not. LODs and LOQs provided for the techniques used herein guarantees a definitive conclusion on the enzyme activity values reported in this work.
The quantitative relevance of XME activities within a toxicity study using zf embryos has to be further investigated, for example by metabolite analysis (Brox et al., 2016) . The chosen substrate concentrations and assay conditions for in vitro investigations might not reflect exposure conditions (and likely less so substance exposure concentrations) in an in vivo study scenario. Furthermore, in this work organisms were necessarily pooled to obtain data, which does not provide an accurate indication of individual biological variability.
All investigated XME in this work play an important role in the metabolism of a large range of xenobiotic substances by accepting them as substrates. It can be noted that enzyme activities were demonstrated to occur at those developmental stages that are also used in many toxicity assays (eg, OECD TG 236). Recent publications (eg, Scholz et al., 2016) demanding proof of metabolic activity in early life stages of zf can be addressed with this study and the results herein. Hence, the role of XME activity demonstrated should be considered when interpreting study outcomes.
